SCHEMBL7987778

SCHEMBL7987778

CCc1nc2ncn(Cc3ccc(OCc4ccccc4)cc3)c2c(=O)[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
HPGD P15428 2/20 0.51
KMT2A Q03164 3/20 0.50
BRD4 O60885 2/20 0.48
GAA P10253 1/20 0.43
NPSR1 Q6W5P4 2/20 0.42
NPC1 O15118 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
TP53 P04637 1/20 0.42
XBP1 P17861 1/20 0.42
GRM2 Q14416 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
RAB9A P51151 1/20 0.42
FAAH O00519 1/20 0.41
MGLL Q99685 1/20 0.41
ACHE P22303 1/20 0.41
MAOB P27338 1/20 0.41
MAPK14 Q16539 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975251 0.90 SMN1; SMN2 (0.60) ALDH1A1SMN1; SMN2HPGDKMT2ABRD4
SCHEMBL7973932 0.86 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2HPGDKMT2ABRD4
SCHEMBL7987442 0.85 HPGD (0.46) ALDH1A1SMN1; SMN2HPGDKMT2ABRD4
SCHEMBL7988126 0.83 HPGD (0.49) ALDH1A1SMN1; SMN2HPGDKMT2ABRD4
SCHEMBL7987785 0.83 PARN (0.47) ALDH1A1SMN1; SMN2HPGDKMT2ABRD4
SCHEMBL7985648 0.83 HPGD (0.47) ALDH1A1SMN1; SMN2HPGDKMT2ABRD4
SCHEMBL7992335 0.82 HPGD (0.44) ALDH1A1SMN1; SMN2HPGDKMT2ABRD4
SCHEMBL7985339 0.82 SMN1; SMN2 (0.56) ALDH1A1SMN1; SMN2HPGDKMT2ABRD4
SCHEMBL7987432 0.82 HPGD (0.47) ALDH1A1SMN1; SMN2HPGDKMT2ABRD4
SCHEMBL7974513 0.82 ADORA3 (0.53) ALDH1A1SMN1; SMN2HPGDKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed